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countries devote around 6,000€ per capita annually, 
compared to others that only spent as little as 350€.  
These increases, along with the global economic crisis, have 
stimulated the interest for more accurate information about 
the exact health care costs and on the way we spent our 
money. Health services research (HSR), a “multidisciplinary 
field of scientific investigation that studies how social 
factors, financing systems, organizational structures and 
processes, health technologies, and personal behaviors affect 
access to health care, the quality and cost of health care, 
and ultimately, our health and well-being” is intended to 
guide the decisions of managers and policy makers about the 
design and implementation of health care programs.  
Heath Technology Assessment (HTA), one component of HSR, 
addresses five central questions related to efficacy, 
effectiveness, efficiency, availability and distribution of 
health care and thus plays an essential role in modern health 
care by supporting evidence-based decision-making in policy 
and practice. Answers to the question of efficiency - or cost-
effectiveness - are typically given by economic evaluations 
(EE). Full EEs involve the quantitative evaluation of both 
costs and outcomes, or consequences, of competing 
interventions. An appropriately performed EE is incremental, 
that is, it measures the extra cost incurred in order to obtain 
the incremental improvement in outcome. Understandably, 
the inputs used to perform such EEs have to be chosen with 
care if one wants to derive results that correctly support 
decision-making on resource allocation. Apart from the 
indispensible data on effectiveness, the accurate 
computation of the cost component is equally important.  
The presentation will zoom in on the above aspects of HSR 
through examples from radiation oncology and evaluate why 
it is important to invest on this type of research. 
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The methodology used to measure cost in economic 
evaluations in healthcare, as in clinical studies, is key to 
determine the health economic study’s robustness. On-going 
literature review, investigating how costing is conducted in 
radiotherapy shows that one third of selected articles did not 
follow any conventional cost accounting methodology 
[Defourny 2015]. This demonstrates the absence of clear 
practices in reporting cost calculation [Graves 2002] and the 
lack of understanding the influence of a cost calculation 
method on final cost results [Doshi, 2006]. 
A feature of the healthcare sector is the coexistence of 
different types of accounting: NHS reimbursement’s billing, 
hospital finance‘s invoices, insurances’ clients’ bills and so 
forth. These similarities tend to create confusion on how to 
implement costing exercises in a clinical study [Kaplan, 
2014]. Cost accounting captures real economic cost not the 
‘financial accounts’ [Mankiw, 2007]. The economic value of 
an expense, commonly known as the opportunity cost, is 
defined as the value of the benefit you could have realized 
by investing the same amount of money in taking the best 
alternative option. Economic theory measures item by 
capturing its opportunity cost in monetary terms. 
Given the interrelated heterogeneous costs in the healthcare 
sector, health economics recommends selecting the relevant 
costs that matches the costing study perspective. Taking all 
other perspectives into account, the societal perspective is 
the most comprehensive approach because it also includes 
the productivity loss of the patient [Drummond 2005]. When 
authors want to inform decision makers about the real cost of 
an intervention, the global cost involved in the delivering of 
treatment, has to be computed, only then is the information 
relevant to explore whether this intervention is cost-efficient 
[Kaplan, 2014]. Conclusively, the relevant evaluation choice 
comes down to what the study wants to determine.  
The method’s choice influences the cost result [Mercier, 
2014]. Authors have to decide on the appropriate costing 
method to use. The choice of sound methodologies will 
facilitate comparisons across studies.Cost accounting 
methods for cost calculation are categorized by an axis 
linking two distinct margins: top-down (activity-based 
costing, ABC) and bottom-up (micro costing). The top-down 
method uses total department expenses as first step to 
untangle the different resource’s costs. The bottom-up 
approach records individual expenses and cumulates it per 
resource types. The advantages of the bottom-up approach 
were merged in a top-down framework in the time-driven 
activity-based costing (TDABC). ABC and micro-costing 
methods assume inherently full resources utilization, only if 
it can be established that the actual number of treatment 
courses delivered by an RT unit is using all the available 
resources, is the result of these cost accounting models 
robust. In contrast, TD ABC method does not start off with 
this premise. By incorporating the actual resource usage rate 
with the state of the art one, this cost method reveals areas 
for the improvement in the allocation of resources. 
Developing a study calculating the real cost of delivering an 
intervention will contribute to “solving the healthcare 
expenses crisis” [Kaplan 2014].  
To conclude, costing methods have to be relevant, sound and 
transparent to be a useful tool to decision maker [Sullivan, 
2011].  
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The field of radiotherapy is innovating rapidly. These 
innovations are often associated with better health, but also 
with higher costs. As healthcare budgets are scarce, we are 
increasingly asked to show that the effects of new 
radiotherapy techniques are worth the extra costs. In this 
presentation I will explain how to undertake such an analysis.  
This presentation provides an introduction to the principles 
and practice of economic evaluation. Topics include different 
types of economic evaluation, trial-based and model-based 
economic evaluation, use of quality-adjusted lifeyears and 
interpreting and presenting evidence. Throughout the 
presentation I will provide practical examples from the field 
of radiotherapy.  
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Purpose/Objective: Range uncertainties in proton therapy 
can be reduced using in-vivo range verification based on 
prompt gamma (PG) imaging. In pencil beam scanning, PG 
emission can be measured for all pencil beams of the 
treatment and compared to the treatment planning in order 
to detect potential range discrepancies. This study proposes 
a strategy to analyze the large amount of PG profiles 
acquired during treatment using a priori simulations. 
Materials and Methods: Pencil beam scanning treatments 
were planned on an anthropomorphic phantom. Brain, nasal 
cavity and lung cases were included in the study. The 
treatments were delivered to the anthropomorphic phantom 
at the Proton Therapy Center in Prague, and PG monitoring 
was performed using a knife-edge slit gamma camera. Both 
single fraction (2 Gy) and full treatment at once (60 Gy) were 
delivered and measured. A dedicated analytical PG simulator 
was used to compute the expected PG profiles for all pencil 
beams of the treatment in the planning configuration. 
Several scenarios, corresponding to several possible sources 
of range discrepancy (i.e. setup errors, CT calibration errors 
and energy errors), were simulated as well. The 
corresponding range shifts were computed based on CSDA 
approximation in order to estimate the range sensitivity. 
Moreover, the range shifts were estimated from the 
simulated profiles using a range retrieval method. The 
difference between CSDA-based shifts and shifts estimated 
from the simulated PG profiles defined the expected 
systematic error in range retrieval for each pencil beam. The 
actual range was then estimated based on the comparison of 
measured and simulated profiles. The range shifts were also 
retrieved from the comparison of 2 Gy and 60 Gy acquisitions 
in order to evaluate an occurrence of the random errors. In 
order to improve range assessment, a selection of the most 
reliable pencil beams was done based on weight and 
expected systematic errors. 
Results: Realistic treatments were successfully delivered to 
an anthropomorphic phantom and monitored using the PG 
camera. Using all pencil beams, the average systematic range 
shift extracted from the comparison of the 60 Gy acquisition 
with the simulation were of 4.1, 5.8 and -4.0 mm for brain, 
nasal cavity and lung, respectively. The average random 
error was of 2.4, 4.5 and 2.2 mm. When selecting the pencil 
beams whose weight was higher than 0.3 MUs and whose 
systematic error was smaller than 1 mm, the systematic 
range shift was 4.1, 6.8 and -3.2, and the random errors went 




Figure: Treatment plan (top-left), experimental setup (top-
right), and range analysis on first energy layer (bottom): (a) 
range sensitivity to energy variations of +/- 3 MeV on first 
layer; (b) systematic error on range retrieval for energy 
variations; (c) range shifts from 60 Gy acquisition; (d) range 
shifts from 2 Gy acquisition. The size of the spots is 
proportional to their weight. 
Conclusions: The first prompt gamma-based range 
monitoring of realistic proton pencil beam scanning 
treatments on an anthropomorphic phantom were 
successfully conducted and a strategy to extract range 
discrepancies was proposed.  
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Purpose/Objective: Radiochromic 3D dosimetry has great 
potential for verification of complex treatment techniques 
such as adaptive radiotherapy and proton therapy. However, 
the response to irradiation is often dependent on dose-rate, 
which can limit their use in clinical environments. Recently, 
we have developed a radiochromic silicone-based 3D 
dosimeter, where the first generation of the dosimeter had 
an issue with dose-rate dependency. However, by changing 
the chemical composition of the dosimeter, we have in this 
study reduced the dose-rate dependence to a clinically 
acceptable level. 
Materials and Methods: The silicone-based dosimeters were 
produced by mixing leuco-malachite green (LMG) dye as the 
active component, 1 % (w/w) chloroform as the initiator and 
a silicone elastomer as the host matrix. All dosimeters were 
left to cure for two days at room temperature. Thereafter 
they were irradiated with a linac to doses in the range 0-30 
Gy, in a 10 cm square field and with a beam quality of 6 MV. 
During irradiation they were placed at SSD 94.5 cm between 
two 5 cm slabs of solid water. Experiments were performed 
at dose-rates of 200 MU/min and 600 MU/min for a series of 
dosimeters with different LMG concentrations. The 
dosimeters were then read-out using a spectrophotometer at 
627 nm before and after irradiation to obtain the change in 
optical density (Δ OD) caused by the irradiation. Δ OD was 
plotted as a function of dose and fitted to a linear expression 
with the slope giving the dose response. The dose-rate 
dependence was then expressed as the percentage difference 
between the dose responses of the two dose-rate 
measurements, relative to the 200 MU/min measurement. 
Results: The dose-rate dependence was greatly reduced with 
increasing dye concentration (Figure). Below 0.05 % (w/w) 
LMG it was observed to be around 17 %, while it was 
eliminated in dosimeters containing 0.25 % (w/w) LMG. For 
higher dye concentrations the dose-rate dependence was 
reversed. Similar observations were made for dosimeters with 
5 % (w/w) chloroform. 
The stability of the dosimeters was found to decrease linearly 
with increasing LMG concentration, with a 50 % decrease 
within a day for a concentration of 0.2 % (w/w) LMG. In 
addition, at the highest concentrations precipitation was 
observed within days to weeks after production. 
